Endoscopic ultrasound-guided therapies in the treatment of gastric varices:An in-depth examination of associated adverse events  

作　　者：Anastasios Manolakis Kyriaki Tsagkidou Konstantinos Eleftherios Koumarelas 

机构地区：[1]Department of Gastroenterology,University of Thessaly School of Medicine,Larisa 41100,Greece [2]Department of Gastroenterology,General Hospital of Larisa,Larisa 41221,Greece [3]Department of Emergency Medicine,General Hospital of Larissa,Larisa 41221,Greece

出　　处：《World Journal of Gastrointestinal Endoscopy》2024年第12期640-646,共7页世界胃肠内镜杂志（英文）

摘　　要：The Baveno VII consensus,released in 2023,recommends that the endoscopic treatment of choice for managing bleeding gastric varices(GV)is endoscopic ultrasound(EUS)-guided treatment,specifically EUS-guided cyanoacrylate(CYA)glue injection.This approach has been endorsed due to its efficacy in controlling bleeding while reducing rebleeding rates,compared to other endoscopic techniques.Despite its efficacy,CYA injection for GV has been linked to rare but serious adverse events,such as glue embolization leading to pulmonary embolism,infection/bacteremia,splenic infarction,intra-procedural and post-procedural complications.The technique for endoscopic obliteration of GV was subsequently refined using EUS guidance,aiming to more accurately direct the injection into the varix,reduce the volume of injected glue,target the perforating vein when possible,and confirm obliteration of GV via Doppler examination.

关 键 词：Gastric varices Endoscopic ultrasound Cyanoacrylate injection COIL Adverse events 

分 类 号：R57[医药卫生—消化系统]